Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study

Author:

Guo Fengzhu12ORCID,Yi Zongbi1ORCID,Wang Wenna1,Han Yiqun1ORCID,Yu Pei3,Zhang Su3ORCID,Ouyang Quchang4,Yan Min5,Wang Xiaojia6,Hu Xichun7,Jiang Zefei8,Huang Tao9,Tong Zhongsheng10,Wang Shusen11ORCID,Yin Yongmei12ORCID,Li Hui13,Yang Runxiang14,Yang Huawei15,Teng Yuee16,Sun Tao17ORCID,Cai Li18,Li Hongyuan19,Chen Xi20,He Jianjun21,Liu Xinlan22,Yang Shune23,Fan Jinhu3,Qiao Youlin3ORCID,Wang Jiayu1,Xu Binghe1ORCID

Affiliation:

1. Department of Medical Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. Department of Breast Cancer Medical Oncology Hunan Cancer Hospital Changsha China

5. Department of Breast Disease Henan Breast Cancer CenterThe affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China

6. Department of Medical Oncology Zhejiang Cancer Hospital Hangzhou China

7. Department of Medical Oncology Fudan University Shanghai Cancer Center Shanghai China

8. Department of Breast Cancer The Fifth Medical Centre of Chinese PLA General Hospital Beijing China

9. Department of Breast and Thyroid Surgery Union HospitalTongji Medical CollegeHuazhong University of Science and Technology Wuhan China

10. Department of Breast Oncology Key Laboratory of Breast Cancer Prevention and Therapy National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital Tianjin China

11. Department of Medical Oncology State Key Laboratory of Oncology in South China Sun Yat‐sen University Cancer Center Guangzhou China

12. Department of Medical Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing China

13. Department of Breast Surgery Sichuan Province Tumor Hospital Chengdu Sichuan China

14. Department of Medical Oncology Yunnan Cancer HospitalKunming Medical University Kunming China

15. Department of Breast Surgery Cancer HospitalGuangxi Medical University Guangxi China

16. Departments of Medical Oncology and Thoracic Surgery The First Hospital of China Medical University Shenyang China

17. Department of Medical Oncology Cancer Hospital of China Medical UniversityLiaoning Cancer Hospital and InstituteKey Laboratory of Liaoning Breast Cancer Research Shenyang China

18. The 4th Department of Internal Medical Oncology Harbin Medical University Cancer Hospital Harbin China

19. Department of the Endocrine and Breast Surgery The First Affiliated Hospital of Chongqing Medical UniversityChongqing Medical University Chongqing China

20. Department of Medicine Oncology 900 Hospital of the Joint Logistics Team Fuzhou China

21. Department of Breast Surgery The First Affiliated Hospital of Xi’an Jiaotong University Xi’an China

22. Department of Oncology General Hospital of Ningxia Medical University Yinchuan Ningxia China

23. Department of Breast Cancer and Lymphoma Affiliated Tumor Hospital of Xinjiang Medical University Urumqi China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3